Application Process, Eligibility & Deadlines

Admission Requirements

• All applicants must be able to commit the full two weeks. The program will run all day, M-F, with evening readings (expect 4-6 hours outside of class time).
• Applicants must have an MD, DMD, PharmD, or PhD and be poised to begin or be actively engaged in basic or clinical research. For those with MDs who are in clinical training programs, it is expected that the clinical portion of training be completed by the time of enrollment (i.e. the clinical year of fellowship or subspecialty training). For MD and DMD applicants only, some prior experience in clinical investigation is suggested.
• This program is designed specifically for those interested in a career in moving scientific discoveries from the laboratory to the bedside (i.e. from pre-clinical discovery to first-in-human trials). The curriculum will have applicability to the development of novel drugs, biologics, devices and biomarker technologies, including imaging.
• Endorsement by the applicant's department chair, division chief, or principal investigator who can answer the question “Why do you think this course is important to the professional development of the applicant?” AND can approve time away from clinical responsibilities to attend the two-week course.
  • Note: The letter of recommendation is heavily considered in the application screening.

Tuition

Free of charge. Harvard Catalyst is sponsoring the course as part of its Postgraduate Education Program.

Application Process

The application process for the June 11-22, 2012 course will open on February 9, 2012 and close at 5 p.m. on March 22, 2012. All application materials, including endorsement letter, should be submitted by the deadline to be eligible.